Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,662,395
+$546,996 QoQ
Shares Held
26,233
+4.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#1,387
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Asset Advisory Services LLC holds $29,712,872 across 11 Drug Manufacturers - General names. JNJ ranks #1 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
26,233 | $6,662,395 | |
| 2 | LLY |
ELI LILLY & Co
|
4,985 | $5,979,159 | |
| 3 | ABBV |
AbbVie Inc.
|
22,814 | $5,740,914 | |
| 4 | PFE |
Pfizer Inc
|
138,613 | $3,337,801 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,955 | $3,078,217 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,813 | $2,697,365 | |
| 7 | AMGN |
Amgen Inc
|
1,448 | $524,349 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,064 | $513,445 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,662,395 | 26,233 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,115,399 | 25,018 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $5,697,747 | 27,532 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $5,124,081 | 27,635 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $4,017,325 | 26,300 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $4,340,364 | 26,172 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $4,375,044 | 30,252 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $4,800,379 | 29,621 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $4,257,494 | 29,129 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $4,198,204 | 26,539 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $3,822,575 | 24,388 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $3,559,822 | 22,856 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $3,555,535 | 21,481 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $3,182,305 | 20,531 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,328,792 | 18,844 | Shares | Sole | 2023-03-08 | |
| 2022-09-30 | $2,967,597 | 18,166 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,108,200 | 17,510 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,895,583 | 16,338 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $2,634,306 | 15,399 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,601,280 | 16,107 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $2,455,614 | 14,906 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,501,078 | 15,218 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,069,232 | 13,148 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $2,077,918 | 13,957 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $2,036,603 | 14,482 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,756,617 | 13,396 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||